Jason Carroll, Ph.D.
Affiliations: | Cambridge Research Institute | Cancer Research UK, Belfast, Northern Ireland, United Kingdom |
Google:
"Jason Carroll"Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hosseinzadeh L, Kikhtyak Z, Laven-Law G, et al. (2024) The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer. Genome Biology. 25: 44 |
| Overman J, Fontaine F, Moustaqil M, et al. (2023) Correction: Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice. Elife. 12 |
| Li Z, Li T, Yates ME, et al. (2023) The EstroGene database reveals diverse temporal, context-dependent, and bidirectional estrogen receptor regulomes in breast cancer. Cancer Research |
| Wu Y, Li Z, Wedn AM, et al. (2023) FOXA1 reprogramming dictates retinoid X receptor response in ESR1 mutant breast cancer. Molecular Cancer Research : McR |
| Li Z, Li T, Yates ME, et al. (2023) EstroGene database reveals diverse temporal, context-dependent and directional estrogen receptor regulomes in breast cancer. Biorxiv : the Preprint Server For Biology |
| Alizadeh-Ghodsi M, Owen KL, Townley SL, et al. (2022) Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer. Cancer Research Communications. 2: 706-724 |
| Parkinson LM, Gillen SL, Woods LM, et al. (2022) The proneural transcription factor ASCL1 regulates cell proliferation and primes for differentiation in neuroblastoma. Frontiers in Cell and Developmental Biology. 10: 942579 |
| Bahl S, Carroll JS, Lupien M. (2022) Chromatin Variants Reveal the Genetic Determinants of Oncogenesis in Breast Cancer. Cold Spring Harbor Perspectives in Medicine |
| Aspros KGM, Carter JM, Hoskin TL, et al. (2022) Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer. Npj Breast Cancer. 8: 20 |
| Li Z, Wu Y, Yates ME, et al. (2022) Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis. Cancer Research |